THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH
发明人:
HARRISON, LEONARD CHARLES,RASHIDI, MARYAM,ZHANG, YUXIA
申请号：
EP13855431
公开号：
EP2919799A4
申请日:
2013.03.25
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
The present disclosure relates to the use of a soluble CD52 glycoprotein in treating diseases regulated by effector T-cells, for example sepsis or multiple sclerosis. The present disclosure also relates to diagnostic methods based on the detection of CD52 expression levels in a subject.
